- As many as 2.3 million new cases of cancer were triggered by viral infections worldwide in 2024, according to new research in The Lancet Oncology. French researchers analyzed a large database of cancer incidence from 2024, looking at specific diagnoses that were attributable to infections. They assessed twelve infections including HIV and found that the bacteria H. pylori, human papillomavirus (HPV), hepatitis B virus (HBV), and Epstein–Barr virus (EBV) had the largest number of cases attributable to them. The researchers concluded that some of these infections, like HPV and HBV, are preventable with vaccines, and that more research for EBV vaccines is needed. EBV has also been linked to multiple sclerosis and Lupus. The study did not assess SARS-CoV-2.
- One in 10 adults stated that COVID-19 worsened a pre-existing health condition long term, according to a new preprint. Researchers conducted a study between 2023 and 2025 that included 2,227 adults from four sites around the U.S. who took three surveys over the course of a year after having COVID-19. “Respondents in our study shared struggles with stress and social isolation as they live with chronic conditions and the risk of reinfection or newly worsening condition,” the authors wrote.
- A recent commentary in NEW SOLUTIONS argues that Long COVID is an occupational disease for teachers. The article states this profession has a high risk of Long COVID and COVID-19 and recommends policies including air cleaning and ventilation to benefit both teachers and students, as well as disability supports compliant with the American with Disabilities Act. “Making these proposed investments in future research and practice to promote teachers’ occupational health could help support and replenish the teacher workforce,” the authors concluded.
More research updates
- Biological pathways and mechanistic trials centered at new Long COVID conference in Amsterdam
- Research updates, October 6
- Research updates, September 29
- People with Long COVID demand pause of McMaster University clinical trial
- Research updates, September 22
- Bezisterim may help with some Long COVID symptoms, drug’s developer reports in early trial results
